ArticleClinical and translational medicine2025
The novel GSDMD inhibitor GI-Y2 exerts antipyroptotic effects to reduce atherosclerosis.
Xiaoxi Fan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it